Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-08

FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CLARAVIS (isotretinoin) filed by Teva Pharmaceuticals USA, Inc. The action pertains to changes to the product's labe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Claravis (isotretinoin)

Snippet

SUPPL AP for CLARAVIS (ISOTRETINOIN)